1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Nephropathy Global Clinical Trials Review, H1, 2015

Nephropathy Global Clinical Trials Review, H1, 2015

  • February 2015
  • -
  • Global Data
  • -
  • 73 pages

Nephropathy Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Nephropathy Global Clinical Trials Review, H1, 2015" provides data on the Nephropathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Nephropathy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Nephropathy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Nephropathy Global Clinical Trials Review, H1, 2015
Table of Contents
Introduction 6
Nephropathy 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Nephropathy to Genito Urinary System And Sex Hormones Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Nephropathy to Genito Urinary System And Sex Hormones Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Nephropathy 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Nephropathy Therapeutics Clinical Trials 30
Prominent Drugs 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Pfizer Inc. 33
Clinical Trial Overview of Pfizer Inc. 33
Novartis AG 34
Clinical Trial Overview of Novartis AG 34
Mallinckrodt plc 35
Clinical Trial Overview of Mallinckrodt plc 35
Rigel Pharmaceuticals, Inc. 36
Clinical Trial Overview of Rigel Pharmaceuticals, Inc. 36
Kliniken der Stadt Koln gGmbH 37
Clinical Trial Overview of Kliniken der Stadt Koln gGmbH 37
AstraZeneca PLC 38
Clinical Trial Overview of AstraZeneca PLC 38
Astellas Pharma Inc. 39
Clinical Trial Overview of Astellas Pharma Inc. 39
Anthera Pharmaceuticals‚ Inc. 40
Clinical Trial Overview of Anthera Pharmaceuticals‚ Inc. 40
AbbVie Inc. 41
Clinical Trial Overview of AbbVie Inc. 41
Clinical Trial Overview of Top Institutes / Government 42
Mayo Clinic 42
Clinical Trial Overview of Mayo Clinic 42
Nanjing Medical University 43
Clinical Trial Overview of Nanjing Medical University 43
Seoul National University Hospital 44
Clinical Trial Overview of Seoul National University Hospital 44
Guangdong General Hospital 45
Clinical Trial Overview of Guangdong General Hospital 45
Regional Hospital Holstebro 46
Clinical Trial Overview of Regional Hospital Holstebro 46
Tehran University of Medical Sciences 47
Clinical Trial Overview of Tehran University of Medical Sciences 47
Leiden University Medical Center 48
Clinical Trial Overview of Leiden University Medical Center 48
Sun Yat-sen University 49
Clinical Trial Overview of Sun Yat-sen University 49
Ospedale Misericordia e Dolce 50
Clinical Trial Overview of Ospedale Misericordia e Dolce 50
Assistance Publique - Hopitaux de Paris 51
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 51
Five Key Clinical Profiles 52
Appendix 71
Abbreviations 71
Definitions 71
Research Methodology 72
Secondary Research 72
About GlobalData 73
Contact Us 73
Disclaimer 73
Source 73

List of Tables

Nephropathy Therapeutics, Global, Clinical Trials by Region, 2015* 7
Nephropathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Nephropathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Nephropathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Nephropathy Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Nephropathy Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Nephropathy Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Nephropathy Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Nephropathy to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015* 15
Nephropathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Nephropathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Nephropathy to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015* 18
Nephropathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Nephropathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Nephropathy Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Nephropathy Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Nephropathy Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Nephropathy Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Nephropathy Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25
Nephropathy Therapeutics, Global, Terminated Clinical Trials, 2015* 26
Nephropathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Nephropathy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 28
Nephropathy Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Nephropathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31
Nephropathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32
Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 33
Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 34
Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Mallinckrodt plc, 2015* 35
Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigel Pharmaceuticals, Inc., 2015* 36
Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Kliniken der Stadt Koln gGmbH, 2015* 37
Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015* 38
Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2015* 39
Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Anthera Pharmaceuticals‚ Inc., 2015* 40
Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2015* 41
Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015* 42
Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Nanjing Medical University, 2015* 43
Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2015* 44
Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Guangdong General Hospital, 2015* 45
Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Regional Hospital Holstebro, 2015* 46
Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2015* 47
Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2015* 48
Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2015* 49
Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Ospedale Misericordia e Dolce, 2015* 50
Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2015* 51

List of Figures

Nephropathy Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Nephropathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Nephropathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Nephropathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Nephropathy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Nephropathy Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Nephropathy Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Nephropathy Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Nephropathy to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015* 15
Nephropathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Nephropathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Nephropathy to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015* 18
Nephropathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Nephropathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Nephropathy Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Nephropathy Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Nephropathy Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Nephropathy Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Nephropathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Nephropathy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 28
Nephropathy Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Nephropathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Nephropathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32
GlobalData Methodology 72

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.